High expression of TCF12 contributes to gastric cancer development via being target regulated by miR‐183 and activating PI3K/AKT pathway

2019 ◽  
Vol 120 (8) ◽  
pp. 13903-13911 ◽  
Author(s):  
Xuekui Wang ◽  
Shen Gao ◽  
Feng Xie ◽  
Wei Li ◽  
Miyang Li ◽  
...  
2020 ◽  
Vol 126 ◽  
pp. 109941 ◽  
Author(s):  
Hu Song ◽  
Yixin Xu ◽  
Teng Xu ◽  
Ruizhi Fan ◽  
Tao Jiang ◽  
...  

2021 ◽  
Vol 12 (11) ◽  
pp. 3277-3290
Author(s):  
Chunmei Li ◽  
Xiaoming Hou ◽  
Shuqiao Yuan ◽  
Yigan Zhang ◽  
Wenzhen Yuan ◽  
...  

Toxins ◽  
2021 ◽  
Vol 13 (3) ◽  
pp. 181
Author(s):  
Masami Suganuma ◽  
Tatsuro Watanabe ◽  
Eisaburo Sueoka ◽  
In Kyoung Lim ◽  
Hirota Fujiki

The tumor necrosis factor-α (TNF-α)-inducing protein (tipα) gene family, comprising Helicobacter pylori membrane protein 1 (hp-mp1) and tipα, has been identified as a tumor promoter, contributing to H. pylori carcinogenicity. Tipα is a unique H. pylori protein with no similarity to other pathogenicity factors, CagA, VacA, and urease. American H. pylori strains cause human gastric cancer, whereas African strains cause gastritis. The presence of Tipα in American and Euro-Asian strains suggests its involvement in human gastric cancer development. Tipα secreted from H. pylori stimulates gastric cancer development by inducing TNF-α, an endogenous tumor promoter, through its interaction with nucleolin, a Tipα receptor. This review covers the following topics: tumor-promoting activity of the Tipα family members HP-MP1 and Tipα, the mechanism underlying this activity of Tipα via binding to the cell-surface receptor, nucleolin, the crystal structure of rdel-Tipα and N-terminal truncated rTipα, inhibition of Tipα-associated gastric carcinogenesis by tumor suppressor B-cell translocation gene 2 (BTG2/TIS21), and new strategies to prevent and treat gastric cancer. Thus, Tipα contributes to the carcinogenicity of H. pylori by a mechanism that differs from those of CagA and VacA.


Sign in / Sign up

Export Citation Format

Share Document